Atlas Trials

Study to Evaluate Safety and Efficacy of LifeLiver in Acute or Acute-on-Chronic Liver Failure Patients

Clinical trial NCT03882346 · UNKNOWN

Trial details

NCT number
NCT03882346
Sponsor
HLB Cell Co., Ltd.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Liver FailureAcute-On-Chronic Liver Failure
Start date
2019-03-29
Primary completion
2022-03-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.